First Citizens Bank & Trust’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$666K Buy
18,281
+751
+4% +$23.7K 0.01% 396
2026
Q1
$491K Sell
17,530
-1,410
-7% -$46.2K 0.01% 438
2025
Q4
$709K Buy
18,940
+59
+0.3% +$1.94K 0.01% 365
2025
Q3
$520K Sell
18,881
-804
-4% -$27.7K 0.01% 429
2025
Q2
$622K Buy
19,685
+13,182
+203% +$424K 0.01% 384
2025
Q1
$216K Buy
+6,503
New +$233K 0.01% 467

Other funds holding HRMY

First Citizens Bank & Trust's HRMY Position: Q2 2026 in Review

First Citizens Bank & Trust increased its Harmony Biosciences (HRMY) stake by 4.3% in Q2 2026, buying an estimated $23.7K and bringing the position to 18,281 shares worth $666K. The position accounts for 0.01% of the portfolio, ranked #396.

First Citizens Bank & Trust first reported a position in HRMY in Q1 2025 and has held it in 6 quarters since. The position peaked at $709K in Q4 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • First Citizens Bank & Trust held 18,281 shares of Harmony Biosciences worth $666K as of Q2 2026.
  • First Citizens Bank & Trust bought 751 Harmony Biosciences shares in Q2 2026, an estimated $23.7K.
  • Harmony Biosciences made up 0.01% of First Citizens Bank & Trust's portfolio in Q2 2026, its #396 holding.
  • First Citizens Bank & Trust first reported a position in Harmony Biosciences in Q1 2025 and has held it in 6 quarters since.
  • First Citizens Bank & Trust's Harmony Biosciences position peaked at $709K in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on First Citizens Bank & Trust's 13F filing for Q2 2026, filed 13 Jul 2026.